Upcoming Events

More

Latest News

Who is Eligible to Submit an Application Under NIH’s Continuous Submission Policy?

March 7, 2017

Appointed members of standing NIH study sections, NIH Boards of Scientific Counselors, NIH Advisory Boards or Councils, or NIH Program Advisory Committees are all eligible for continuous submission (submitting R01, R21, and R34 applications at any time in response to active funding opportunity announcements (FOAs) that have standard due dates).

How Can I Check If I Am Eligible to Submit an Application Under NIH’s Continuous Submission Policy?

March 7, 2017

NIH’s continuous submission policy provides members of review and advisory groups and reviewers with recent substantial service the benefit of submitting R01, R21, and R34 applications at any time in response to active funding opportunity announcements (FOAs) that have standard due dates. Check your eligibility to submit applications under NIH’s continuous submission policy by logging into eRA Commons, and following the instructions outlined here.

Research Answers to NCI's Provocative Questions (R01)

March 3, 2017

Funding Opportunity RFA-CA-17-017 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support research projects designed to solve specific problems and paradoxes in cancer research identified by the National Cancer Institute (NCI) Provocative Questions initiative. These problems and paradoxes phrased as questions are not intended to represent the full range of NCI's priorities in cancer research.

Research Answers to NCI's Provocative Questions (R21)

March 3, 2017

Funding Opportunity RFA-CA-17-018 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support research projects designed to solve specific problems and paradoxes in cancer research identified by the National Cancer Institute (NCI) Provocative Questions initiative. These problems and paradoxes phrased as questions are not intended to represent the full range of NCI's priorities in cancer research.

More<embed>
Copy and paste this code to your website.